Trials / Conditions / Albright Hereditary Osteodystrophy

Albright Hereditary Osteodystrophy

8 registered clinical trials studyying Albright Hereditary Osteodystrophy — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old NCT04551170	Vanderbilt University Medical Center	Phase 2
Enrolling By Invitation	Theophylline for Treatment of Pseudohypoparathyroidism NCT04240821	Ashley Shoemaker	Phase 2
Terminated	Glucose Homeostasis in Pseudohypoparathyroidism NCT03761290	Vanderbilt University Medical Center	—
Active Not Recruiting	Theophylline Treatment for Pseudohypoparathyroidism NCT03029429	Vanderbilt University Medical Center	Phase 2
Completed	Theophylline as a Treatment for Children With Pseudohypoparathyroidism Type 1a (Albright Hereditary Osteodystr NCT02463409	Vanderbilt University Medical Center	Phase 2
Completed	Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism NCT02411461	Vanderbilt University Medical Center	—
Terminated	Energy Expenditure and Body Composition in Pseudohypoparathyroidism 1a NCT01398774	Children's Hospital of Philadelphia	—
Recruiting	Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments NCT00209235	Connecticut Children's Medical Center	N/A